| Date Filed | Type | Description |
| 10/10/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/10/2023 |
SC 13G
| Point72 Asset Management, L.P. reports a 5.1% stake in Rapid7, Inc. |
| 10/05/2023 |
SC 13G
| Point72 Asset Management, L.P. reports a 5.6% stake in Vistagen Therapeutics, Inc. |
| 10/05/2023 |
SC 13G
| Point72 Asset Management, L.P. reports a 5% stake in TPI Composites, Inc. |
| 10/02/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 09/29/2023 |
SC 13G
| Point72 Asset Management, L.P. reports a 8.1% stake in Bionomics Limited |
| 08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 07/27/2023 |
SC 13G
| Point72 Asset Management, L.P. reports a 6.2% stake in Turnstone Biologics Corp. |
| 07/27/2023 |
SC 13G
| Point72 Asset Management, L.P. reports a 5% stake in Health Catalyst, Inc. |
| 07/20/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/20/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/01/2023 |
SC 13G
| Point72 Asset Management, L.P. reports a 5% stake in Cogent Biosciences, Inc. |
| 05/24/2023 |
SC 13G
| Point72 Asset Management, L.P. reports a 8.7% stake in Elevation Oncology, Inc. |
| 05/16/2023 |
SC 13G
| Point72 Asset Management, L.P. reports a 5.8% stake in Cutera, Inc. |
| 05/15/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/15/2023 |
13F-HR/A
| Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend] |
| 04/05/2023 |
SC 13G
| Point72 Asset Management, L.P. reports a 5% stake in Esperion Therapeutics, Inc. |
| 03/09/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 1.2% stake in Cepton, Inc. |
| 02/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a |
| 02/14/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 0% stake in Progress Acquisition Corp. |
| 02/14/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 2.2% stake in Praxis Precision Medicines, Inc. |
| 02/14/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 4.4% stake in Axogen, Inc. |
| 02/14/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 1.6% stake in BellRing Brands, Inc. |
| 02/14/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 0% stake in Otonomy, Inc. |
| 02/14/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 0.2% stake in Atara Biotherapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 0% stake in Minerva Neurosciences, Inc. |
| 02/14/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 1.9% stake in Arcutis Biotherapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 0% stake in Merrimack Pharmaceuticals, Inc. |
| 02/14/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 3.2% stake in Applied Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a |
| 02/14/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 0.2% stake in Akero Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 2.2% stake in Krystal Biotech, Inc. |
| 02/14/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 2.8% stake in Affimed N.V. |
|